Effect of WNT-1 on β-catenin expression and its relation to Ki-67 and tumor differentiation in oral squamous cell carcinoma

Oncology Reports

Volumn 13, Issue 6, 2005, Pages 1095-1099

  Zhang, Wei Min ^a   Lo Muzio, Lorenzo ^b   Rubini, Corrado ^c   Yan, Gao ^a  

^a PEKING UNIVERSITY   (China)

^b UNIVERSITY OF FOGGIA   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Cadherin; Carcinogenesis; Catenin; Head and neck; Ki 67; Oral; Squamous cell carcinoma; WNT 1

Indexed keywords

BETA CATENIN; CADHERIN; CTNNB1 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; DESMOPLAKIN; JUP PROTEIN, HUMAN; KI 67 ANTIGEN; PLAKOGLOBIN; SIGNAL PEPTIDE; TRANSACTIVATOR PROTEIN; TUMOR MARKER; WNT PROTEIN; WNT1 PROTEIN; WNT1 PROTEIN, HUMAN;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; MOUTH TUMOR; PATHOLOGY; PRECANCER; SQUAMOUS CELL CARCINOMA;

BETA CATENIN; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOSKELETAL PROTEINS; DESMOPLAKINS; GAMMA CATENIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KI-67 ANTIGEN; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; WNT PROTEINS; WNT1 PROTEIN;

EID: 24744460574     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.13.6.1095     Document Type: Article

References (42)

1. Raybaud-Diogene H, Tetu B, Morency R, Fortin A and Monteil RA: p53 overexpression in head and neck squamous cell carcinoma: review of the literature. Eur J Cancer B Oral Oncol 32: 143-149, 1996.
2. Dale TC: Signal transduction by the Wnt family of ligands. Biochem J 329: 209-223, 1998.
3. Thorpe CJ, Schlesinger A and Bowerman B: Wnt signalling in Caenorhabditis elegans: regulating repressors and polarizing the cytoskeleton. Trends Cell Biol 10: 10-17, 2000. (Pubitemid 30017861)
4. 2+pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet 16: 279-283, 2000.
5. Bienz M: Spindles cotton on to junctions, APC and EB1. Nat Cell Biol 3: E67-68, 2001.
6. Dahmen RP, Koch A, Denkhaus D, et al: Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res 61: 7039-7043, 2001. (Pubitemid 32946492)
7. Miyoshi Y, Iwao K, Nagasawa Y, et al: Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res 58: 2524-2527, 1998. (Pubitemid 28275419)
8. Su LK, Vogelstein B and Kinzler KW: Association of the APC tumor suppressor protein with catenins. Science 262: 1734-1737, 1993. (Pubitemid 24030097)
9. Morin PJ, Medina M, Semenov M, Brown AM and Kosik KS: Wnt-1 expression in PC12 cells induces exon 15 deletion and expression of L-APP. Neurobiol Dis 16: 59-67, 2004. (Pubitemid 38569796)
10. You L, He B, Uematsu K, et al: Inhibition of Wnt-1 signaling induces apoptosis in beta-catenin-deficient mesothelioma cells. Cancer Res 64: 3474-3478, 2004. (Pubitemid 38657920)
11. Kanei-Ishii C, Ninomiya-Tsuji J, Tanikawa J, et al: Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK. Genes Dev 18: 816-829, 2004. (Pubitemid 38480893)
12. He B, You L, Uematsu K, et al: A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. Neoplasia 6: 7-14, 2004. (Pubitemid 38391944)
13. Gumbiner BM and McCrea PD: Catenins as mediators of the cytoplasmic functions of Cadherins. J Cell Sci Suppl 17: 155-158, 1993. (Pubitemid 24041293)
14. Miller JR and Moon RT: Signal transduction through beta-catenin and specification of cell fate during embryogenesis. Genes Dev 10: 2527-2539, 1996. (Pubitemid 26357220)
15. Behrens J, von Kries JP, Kuhl M, et al: Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382: 638-642, 1996. (Pubitemid 26268958)
16. Brunner E, Peter O, Schweizer L and Basler K: Pangolin encodes a Lef-1 homologue that acts downstream of armadillo to transduce the wingless signal in Drosophila. Nature 385: 829-833, 1997. (Pubitemid 27106074)
17. Allison RT and Best T: p53, PCNA and Ki-67 expression in oral squamous cell carcinomas: the vagaries of fixation and microwave enhancement of immunocytochemistry. J Oral Pathol Med 27: 434-440, 1998. (Pubitemid 28490132)
18. Iamaroon A, Khemaleelakul U, Pongsiriwet S and Pintong J: Co-expression of p53 and Ki67 and lack of EBV expression in oral squamous cell carcinoma. J Oral Pathol Med 33: 30-36, 2004. (Pubitemid 38159974)
19. Thomson PJ, Soames JV, Booth C and O'Shea JA: Epithelial cell proliferative activity and oral cancer progression. Cell Prolif 35: 110-120, 2002. (Pubitemid 34985154)
20. Carinci F, Stabellini G, Calvitti M, et al: CD44 as prognostic factor in oral and oropharyngeal squamous cell carcinoma. J Craniofac Surg 13: 85-89, 2002. (Pubitemid 34873952)
21. Rhee CS, Sen M, Lu D, et al: Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene 21: 6598-6605, 2002. (Pubitemid 35177038)
22. Uraguchi M, Morikawa M, Shirakawa M, Sanada K and Imai K: Activation of WNT family expression and signaling in squamous cell carcinomas of the oral cavity. J Dent Res 83: 327-332, 2004. (Pubitemid 41713770)
23. Nusse R, van Ooyen A, Cox D, Fung YK and Varmus H: Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature 307: 131-136, 1984. (Pubitemid 14132897)
24. Lo Muzio L, Pannone G, Staibano S, et al: WNT-1 expression in basal cell carcinoma of head and neck. An immunohistochemical and confocal study with regard to the intracellular distribution of beta-catenin. Anticancer Res 22: 565-576, 2002. (Pubitemid 34475202)
25. Andrews NA, Jones AS, Helliwell TR and Kinsella AR: Expression of the E-cadherin-catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases. Br J Cancer 75: 1474-1480, 1997. (Pubitemid 27196868)
26. Bagutti C, Speight PM and Watt FM: Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity. J Pathol 186: 8-16, 1998. (Pubitemid 28407482)
27. Williams HK, Sanders DS, Jankowski JA, Landini G and Brown AM: Expression of Cadherins and catenins in oral epithelial dysplasia and squamous cell carcinoma. J Oral Pathol Med 27: 308-317, 1998. (Pubitemid 28382637)
28. Lo Muzio L, Staibano S, Pannone G, et al: Beta- and gamma-catenin expression in oral squamous cell carcinomas. Anticancer Res 19: 3817-3826, 1999.
29. Chow V, Yuen AP, Lam KY, Tsao GS, Ho WK and Wei WI: A comparative study of the clinicopathological significance of E-cadherin and catenins (alpha, beta, gamma) expression in the surgical management of oral tongue carcinoma. J Cancer Res Clin Oncol 127: 59-63, 2001.
30. Bankfalvi A, Krassort M, Buchwalow IB, Vegh A, Felszeghy E and Piffko J: Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression. J Pathol 198: 343-351, 2002. (Pubitemid 35277385)
31. Bankfalvi A, Krassort M, Vegh A, Felszeghy E and Piffko J: Deranged expression of the E-cadherin/beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas. J Oral Pathol Med 31: 450-457, 2002.
32. Gasparoni A, Chaves A, Fonzi L, Johnson GK, Schneider GB and Squier CA: Subcellular localization of beta-catenin in malignant cell lines and squamous cell carcinomas of the oral cavity. J Oral Pathol Med 31: 385-394, 2002. (Pubitemid 34973685)
33. Tanaka N, Odajima T, Ogi K, Ikeda T and Satoh M: Expression of E-cadherin, alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. Br J Cancer 89: 557-563, 2003. (Pubitemid 37026443)
34. Inukai T, Furuuchi K, Sugita K, et al: Nuclear accumulation of beta-catenin without an additional somatic mutation in coding region of the APC gene in hepatoblastoma from a familial adenomatous polyposis patient. Oncol Rep 11: 121-126, 2004.
35. Fujito T, Sasaki Y, Iwao K, et al: Prognostic significance of beta-catenin nuclear expression in hepatocellular carcinoma. Hepatogastroenterology 51: 921-924, 2004. (Pubitemid 38822437)
36. Park WS, Oh RR, Park JY, et al: Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma. J Pathol 193: 483-490, 2001. (Pubitemid 32266817)
37. Mao TL, Chu JS, Jeng YM, Lai PL and Hsu HC: Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis. J Pathol 193: 95-101, 2001.
38. Terris B, Pineau P, Brcgeaud L, et al: Close correlation between beta-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinomas. Oncogene 18: 6583-6588, 1999.
39. Nhieu JT, Renard CA, Wei Y, Cherqui D, Zafrani ES and Buendia MA: Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation. Am J Pathol 155: 703-710, 1999. (Pubitemid 29426815)
40. Brabletz T, Herrmann K, Jung A, Faller G and Kirchner T: Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am J Pathol 156: 865-870, 2000. (Pubitemid 30626945)
41. Orsulic S, Huber O, Aberle H, Arnold S and Kemier R: E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. J Cell Sci 112: 1237-1245, 1999. (Pubitemid 29218912)
42. Jamora C and Fuchs E: Intercellular adhesion, signalling and the cytoskeleton. Nat Cell Biol 4: E101-108, 2002. (Pubitemid 34308851)